Experienced in Chronic Lymphocytic Leukemia (CLL)

Dr. Douglas W. Orr

Oncology | Internal Medicine
Baylor Scott & White Health
Texas Oncology, P.A.
7777 Forest Ln Bldg C, Ste 707, 
Dallas, TX 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
48 Years of Experience
Experienced in Chronic Lymphocytic Leukemia (CLL)
Baylor Scott & White Health
Texas Oncology, P.A.
7777 Forest Ln Bldg C, Ste 707, 
Dallas, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Douglas Orr is an Oncologist and an Internal Medicine provider in Dallas, Texas. Dr. Orr has been practicing medicine for over 48 years and is rated as an Experienced provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). His top areas of expertise are Fibrolamellar Carcinoma, Gastric Lymphoma, Myeloproliferative Neoplasms (MPN), and Liver Cancer.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Vanderbilt University School Of Medicine, 1978.0
Residency
Internal Medicine, Vanderbilt University Medicial Center
Specialties
Oncology
Internal Medicine
Licenses
Internal Medicine in TX
Board Certifications
American Board Of Internal Medicine
Fellowships
Medical Oncology, Johns Hopkins Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
FirstCare
  • HMO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Scott and White Health
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Texas Oncology, P.A.
7777 Forest Ln Bldg C, Ste 707, Dallas, TX 75230
Call: 972-449-0540
Other Locations
Mary Crowley Cancer Research Center
7777 Forest Ln, C707, Dallas, TX 75230
Call: 972-566-3000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A First-in-Human, Multicenter, Phase 1/2, Open-Label Study of Vilastobart (XTX101) Monotherapy and Vilastobart (XTX101) and Atezolizumab Combination Therapy in Patients With Advanced Solid Tumors
A First-in-Human, Multicenter, Phase 1/2, Open-Label Study of Vilastobart (XTX101) Monotherapy and Vilastobart (XTX101) and Atezolizumab Combination Therapy in Patients With Advanced Solid Tumors
Enrollment Status: Recruiting
Publish Date: May 29, 2025
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Dose Escalation and Expansion Clinical Study to Evaluate the Safety and Efficacy of ELU001 in Subjects Who Have Advanced, Recurrent or Refractory FRα Overexpressing Tumors
Dose Escalation and Expansion Clinical Study to Evaluate the Safety and Efficacy of ELU001 in Subjects Who Have Advanced, Recurrent or Refractory FRα Overexpressing Tumors
Enrollment Status: Terminated
Publish Date: August 07, 2024
Intervention Type: Drug
Study Drug: ELU001
Study Phase: Phase 1/Phase 2
A Phase 1 Study of SY 5609, an Oral, Selective CDK7 Inhibitor, in Adult Patients With Select Advanced Solid Tumors
A Phase 1 Study of SY 5609, an Oral, Selective CDK7 Inhibitor, in Adult Patients With Select Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: October 27, 2023
Intervention Type: Drug
Study Drugs: SY-5609, Fulvestrant
Study Phase: Phase 1
View 2 Less Clinical Trial

3 Total Publications

ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors.
ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors.
Journal: Cancer research communications
Published: February 23, 2024
View All 3 Publications
Similar Doctors
Elite in Chronic Lymphocytic Leukemia (CLL)
Dr. Farrukh T. Awan
Hematology Oncology | Hematology | Oncology
Elite in Chronic Lymphocytic Leukemia (CLL)
Dr. Farrukh T. Awan
Hematology Oncology | Hematology | Oncology

University Of Texas Southwestern Medical Center At Dallas

6201 Harry Hines Blvd, 
Dallas, TX 
 (7.7 miles away)
214-633-5555
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Farrukh Awan is a Hematologist Oncology specialist and a Hematologist in Dallas, Texas. Dr. Awan is rated as an Elite provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Distinguished in Chronic Lymphocytic Leukemia (CLL)
Dr. Robert H. Collins
Hematology Oncology | Hematology | Oncology
Distinguished in Chronic Lymphocytic Leukemia (CLL)
Dr. Robert H. Collins
Hematology Oncology | Hematology | Oncology

University Of Texas Southwestern Medical Center At Dallas

2201 Inwood Rd, 
Dallas, TX 
 (7.5 miles away)
214-645-2700
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Robert Collins is a Hematologist Oncology specialist and a Hematologist in Dallas, Texas. Dr. Collins is rated as a Distinguished provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). His top areas of expertise are Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Advanced in Chronic Lymphocytic Leukemia (CLL)
Dr. John Mathews
Oncology
Advanced in Chronic Lymphocytic Leukemia (CLL)
Dr. John Mathews
Oncology

Texas Oncology PA

7777 Forest Ln, Suite D220, 
Dallas, TX 
 (0.1 miles away)
972-566-7790
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Mathews is an Oncologist in Dallas, Texas. Dr. Mathews is rated as a Distinguished provider by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). His top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Bone Marrow Aspiration, and Colonoscopy. Dr. Mathews is currently accepting new patients.

VIEW MORE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Orr's expertise for a condition
ConditionClose
    • Distinguished
    • Fibrolamellar Carcinoma
      Dr. Orr is
      Distinguished
      . Learn about Fibrolamellar Carcinoma.
      See more Fibrolamellar Carcinoma experts
    • Advanced
    • Gastric Lymphoma
      Dr. Orr is
      Advanced
      . Learn about Gastric Lymphoma.
      See more Gastric Lymphoma experts
    • Liver Cancer
      Dr. Orr is
      Advanced
      . Learn about Liver Cancer.
      See more Liver Cancer experts
    • Myeloproliferative Neoplasms (MPN)
      Dr. Orr is
      Advanced
      . Learn about Myeloproliferative Neoplasms (MPN).
      See more Myeloproliferative Neoplasms (MPN) experts
    • Experienced
    • Adult Soft Tissue Sarcoma
      Dr. Orr is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Agranulocytosis
      Dr. Orr is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Orr is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Alveolar Soft Part Sarcoma
      Dr. Orr is
      Experienced
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    • Angiosarcoma
      Dr. Orr is
      Experienced
      . Learn about Angiosarcoma.
      See more Angiosarcoma experts
    • Bone Tumor
      Dr. Orr is
      Experienced
      . Learn about Bone Tumor.
      See more Bone Tumor experts
    View All 72 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Close
        0 / 1000

        Please provide us with the below insurance information:

                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.